30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Matt Foehr

Track

Insider profile

Currently holds positions in Viking Therapeutics Inc, Qualigen Therapeutics Inc and Ligand Pharmaceuticals Inc

Performance

Overall performance
3.6
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 13% 8.2% 15.1%
Success rate 77% 68% 82%
Transactions
27 52% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 70%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Director Viking Therapeutics Inc May 1, 2014 -
Independent Director Qualigen Therapeutics Inc Feb. 1, 2015 -
President, Chief Operating Officer Ligand Pharmaceuticals Inc Jan. 27, 2015 -
Chief Operating Officer, Executive Vice President Ligand Pharmaceuticals Inc April 18, 2011 - Jan. 27, 2015
Matt Foehr's trades of OmniAb Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-07 2026-04-07
US OmniAb Inc (OABI)
S Sale
7,258 -36.0%
227.72
US$3,243,902 		7,258 -36.0% 227.72 US$3,243,902
2026-04-07 2026-04-07
US OmniAb Inc (OABI)
PrS Proposed sale
49,784
466.79
US$1,347,454 		49,784 466.79 US$1,347,454
2026-02-18 2026-02-18
US OmniAb Inc (OABI)
S Sale
13,424 -24.9%
367.97
US$3,852,969 		13,424 -24.9% 367.97 US$3,852,969
2026-02-17 2026-02-18
US OmniAb Inc (OABI)
PrS Proposed sale
30,451
1.70
US$51,767 		30,451 1.70 US$51,767
2026-02-17 2026-02-17
US OmniAb Inc (OABI)
S Sale
20,754 -0.5%
1.70
US$35,282 		20,754 -0.5% 1.70 US$35,282
2026-02-17 2026-02-17
US OmniAb Inc (OABI)
PrS Proposed sale
20,483
1.70
US$34,821 		20,483 1.70 US$34,821
2026-01-05 2026-01-02
S Sale
16,000 -10.8%
35.11
US$561,694 		16,000 -10.8% 35.11 US$561,694
2026-01-02 2026-01-02
PrS Proposed sale
16,000
35.11
US$561,694 		16,000 35.11 US$561,694
2025-12-09 2025-12-08
US OmniAb Inc (OABI)
S Sale
13,666 -0.3%
1.96
US$26,785 		13,666 -0.3% 1.96 US$26,785
2025-12-08 2025-12-08
US OmniAb Inc (OABI)
PrS Proposed sale
13,666
1.96
US$26,798 		13,666 1.96 US$26,798
2025-04-07 2025-04-07
US OmniAb Inc (OABI)
PrS Proposed sale
19,382
2.00
US$38,715 		19,382 2.00 US$38,715
2025-04-07 2025-04-07
US OmniAb Inc (OABI)
S Sale
19,382 -0.5%
2.00
US$38,764 		19,382 -0.5% 2.00 US$38,764
2025-02-19 2025-02-19
US OmniAb Inc (OABI)
S Sale
19,522 -0.5%
3.67
US$71,646 		19,522 -0.5% 3.67 US$71,646
2025-02-18 2025-02-19
US OmniAb Inc (OABI)
PrS Proposed sale
19,167
3.68
US$70,538 		19,167 3.68 US$70,538
2025-02-19 2025-02-18
US OmniAb Inc (OABI)
S Sale
13,964 -0.4%
3.68
US$51,388 		13,964 -0.4% 3.68 US$51,388
2025-02-18 2025-02-18
US OmniAb Inc (OABI)
PrS Proposed sale
13,964
3.68
US$51,390 		13,964 3.68 US$51,390
2025-01-22 2025-01-21
US OmniAb Inc (OABI)
S Sale
41,811 -1.1%
3.24
US$135,468 		41,811 -1.1% 3.24 US$135,468
2025-01-21 2025-01-21
US OmniAb Inc (OABI)
PrS Proposed sale
41,811
3.24
US$135,378 		41,811 3.24 US$135,378
2024-12-10 2024-12-09
US OmniAb Inc (OABI)
S Sale
13,634 -0.4%
4.13
US$56,308 		13,634 -0.4% 4.13 US$56,308
2024-12-09 2024-12-09
US OmniAb Inc (OABI)
PrS Proposed sale
13,634
4.13
US$56,245 		13,634 4.13 US$56,245
2024-05-28 2024-05-24
US OmniAb Inc (OABI)
B Purchase
240,000 +7.3%
4.42
US$1,059,840 		240,000 +7.3% 4.42 US$1,059,840
2024-03-25 2024-03-22
US OmniAb Inc (OABI)
B Purchase
225,000 +8.4%
5.19
US$1,167,750 		225,000 +8.4% 5.19 US$1,167,750
2023-12-13 2023-12-12
US OmniAb Inc (OABI)
B Purchase
200,000 +8.2%
5.05
US$1,010,000 		200,000 +8.2% 5.05 US$1,010,000
2023-11-13 2023-11-10
US OmniAb Inc (OABI)
B Purchase
95,000 +4.1%
4.27
US$405,517 		95,000 +4.1% 4.27 US$405,517
2023-08-15 2023-08-14
US OmniAb Inc (OABI)
B Purchase
45,000 +2.0%
5.48
US$246,600 		45,000 +2.0% 5.48 US$246,600
2023-06-12 2023-06-09
US OmniAb Inc (OABI)
B Purchase
115,000 +4.7%
4.52
US$519,800 		115,000 +4.7% 4.52 US$519,800
2023-05-15 2023-05-12
US OmniAb Inc (OABI)
B Purchase
440,000 +22.0%
3.40
US$1,496,000 		440,000 +22.0% 3.40 US$1,496,000
2022-12-14 2022-12-12
US OmniAb Inc (OABI)
B Purchase
150,000 +8.9%
3.77
US$564,765 		150,000 +8.9% 3.77 US$564,765
2022-12-01 2022-11-30
US OmniAb Inc (OABI)
B Purchase
300,000 +21.3%
3.39
US$1,016,340 		300,000 +21.3% 3.39 US$1,016,340
2022-11-09 2022-11-09
US OmniAb Inc (OABI)
B Purchase
100,000 +7.7%
2.76
US$276,160 		100,000 +7.7% 2.76 US$276,160
2022-05-13 2022-05-13
B Purchase
2,500 +1.5%
82.76
US$206,910 		2,500 +1.5% 82.76 US$206,910
2022-05-03 2022-05-02
B Purchase
45,000 +67.9%
2.47
US$111,195 		45,000 +67.9% 2.47 US$111,195
2021-11-12 2021-11-11
S Sale
11,160 -6.3%
163.02
US$1,819,255 		11,160 -6.3% 163.02 US$1,819,255
2021-08-05 2021-08-04
S Sale
8,840 -5.1%
109.67
US$969,507 		8,840 -5.1% 109.67 US$969,507
2021-06-10 2021-06-10
B Purchase
20,000 +43.2%
5.69
US$113,800 		20,000 +43.2% 5.69 US$113,800
2021-02-05 2021-02-04
S Sale
44,547 -20.9%
176.86
US$7,878,582 		44,547 -20.9% 176.86 US$7,878,582
2020-08-25 2020-08-24
PlS Planned sale
78 -0.1%
110.89
US$8,649 		78 -0.1% 110.89 US$8,649
2020-08-25 2020-08-21
PlS Planned sale
7,225 -4.4%
112.88
US$815,541 		7,225 -4.4% 112.88 US$815,541
2020-02-27 2020-02-27
PlS Planned sale
7,225 -4.5%
110.00
US$794,750 		7,225 -4.5% 110.00 US$794,750
2020-02-18 2020-02-14
PlS Planned sale
7,225 -4.4%
95.84
US$692,467 		7,225 -4.4% 95.84 US$692,467
2016-11-15 2016-11-15
B Purchase
13,000 +49.5%
1.21
US$15,678 		13,000 +49.5% 1.21 US$15,678
2015-05-05 2015-05-04
B Purchase
6,250 +inf%
8.00
US$50,000 		6,250 +inf% 8.00 US$50,000